186 related articles for article (PubMed ID: 19276279)
1. Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.
Bass SE; Sienkiewicz P; Macdonald CJ; Cheng RY; Sparatore A; Del Soldato P; Roberts DD; Moody TW; Wink DA; Yeh GC
Clin Cancer Res; 2009 Mar; 15(6):1964-72. PubMed ID: 19276279
[TBL] [Abstract][Full Text] [Related]
2. Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro.
Ciolino HP; MacDonald CJ; Memon OS; Bass SE; Yeh GC
Carcinogenesis; 2006 Aug; 27(8):1586-92. PubMed ID: 16531450
[TBL] [Abstract][Full Text] [Related]
3. Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation.
MacDonald CJ; Cheng RYS; Roberts DD; Wink DA; Yeh GC
J Biol Chem; 2009 Aug; 284(33):22099-22107. PubMed ID: 19542225
[TBL] [Abstract][Full Text] [Related]
4. Sulindac and its metabolites induce carcinogen metabolizing enzymes in human colon cancer cells.
Ciolino HP; Bass SE; MacDonald CJ; Cheng RY; Yeh GC
Int J Cancer; 2008 Mar; 122(5):990-8. PubMed ID: 17985343
[TBL] [Abstract][Full Text] [Related]
5. A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1, -1A2 and -1B1 by preventing activation of the aryl hydrocarbon receptor.
Sienkiewicz P; Ciolino HP; Leslie BJ; Hergenrother PJ; Singletary K; Yeh GC
Carcinogenesis; 2007 May; 28(5):1052-7. PubMed ID: 17183067
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol.
Ciolino HP; Yeh GC
Mol Pharmacol; 1999 Oct; 56(4):760-7. PubMed ID: 10496959
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway.
Maayah ZH; Ghebeh H; Alhaider AA; El-Kadi AO; Soshilov AA; Denison MS; Ansari MA; Korashy HM
Toxicol Appl Pharmacol; 2015 Apr; 284(2):217-26. PubMed ID: 25697376
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene.
Li W; Harper PA; Tang BK; Okey AB
Biochem Pharmacol; 1998 Sep; 56(5):599-612. PubMed ID: 9783729
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
[TBL] [Abstract][Full Text] [Related]
11. Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells.
Ciolino HP; Daschner PJ; Wang TT; Yeh GC
Biochem Pharmacol; 1998 Jul; 56(2):197-206. PubMed ID: 9698073
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor.
Ciolino HP; Daschner PJ; Yeh GC
Cancer Res; 1998 Dec; 58(24):5707-12. PubMed ID: 9865727
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs.
Dell'Omo G; Crescenti D; Vantaggiato C; Parravicini C; Borroni AP; Rizzi N; Garofalo M; Pinto A; Recordati C; Scanziani E; Bassi FD; Pruneri G; Conti P; Eberini I; Maggi A; Ciana P
Br J Cancer; 2019 Mar; 120(5):537-546. PubMed ID: 30739913
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one.
Ciolino HP; MacDonald CJ; Yeh GC
Cancer Res; 2002 Jul; 62(13):3685-90. PubMed ID: 12097275
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes.
Beedanagari SR; Bebenek I; Bui P; Hankinson O
Toxicol Sci; 2009 Jul; 110(1):61-7. PubMed ID: 19376845
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cells.
Liggett JL; Choi CK; Donnell RL; Kihm KD; Kim JS; Min KW; Noegel AA; Baek SJ
Biochim Biophys Acta; 2014 Jan; 1840(1):322-31. PubMed ID: 24080406
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase.
Korashy HM; El-Kadi AO
Toxicology; 2012 Jan; 291(1-3):113-21. PubMed ID: 22120038
[TBL] [Abstract][Full Text] [Related]
19. The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
MacDonald CJ; Ciolino HP; Yeh GC
Cancer Res; 2004 Jan; 64(1):429-34. PubMed ID: 14729655
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional induction of CYP1A1 by oltipraz in human Caco-2 cells is aryl hydrocarbon receptor- and calcium-dependent.
Le Ferrec E; Lagadic-Gossmann D; Rauch C; Bardiau C; Maheo K; Massiere F; Le Vee M; Guillouzo A; Morel F
J Biol Chem; 2002 Jul; 277(27):24780-7. PubMed ID: 11959854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
